Literature DB >> 17400063

Application of human leukocyte antigen-G expression in the diagnosis of human cancer.

Ie-Ming Shih1.   

Abstract

It has been well known that human leukocyte antigen (HLA)-G molecules are present in a variety of human neoplastic diseases, and the molecule may contribute to the escape of tumor cells from immune surveillance. Besides the studies that aim at elucidating the roles of HLA-G in immune regulation, the researches that focus on potential applications of HLA-G expression in cancer diagnosis represent another perspective in HLA-G research. This review summarizes those recent translational studies of HLA-G expression in the diagnosis of human cancer. Specifically, the promises and challenges for applying HLA-G expression to detect cancer in body fluids, to diagnose different types of human cancer and to predict clinical outcome in cancer patients will be briefly reviewed.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17400063      PMCID: PMC1905833          DOI: 10.1016/j.humimm.2007.01.010

Source DB:  PubMed          Journal:  Hum Immunol        ISSN: 0198-8859            Impact factor:   2.850


  20 in total

1.  Detection of soluble HLA-G molecules in plasma and amniotic fluid.

Authors:  V Rebmann; K Pfeiffer; M Pässler; S Ferrone; S Maier; E Weiss; H Grosse-Wilde
Journal:  Tissue Antigens       Date:  1999-01

2.  Association of soluble HLA-G plasma levels with HLA-G alleles.

Authors:  V Rebmann; K van der Ven; M Pässler; K Pfeiffer; D Krebs; H Grosse-Wilde
Journal:  Tissue Antigens       Date:  2001-01

3.  A class I antigen, HLA-G, expressed in human trophoblasts.

Authors:  S Kovats; E K Main; C Librach; M Stubblebine; S J Fisher; R DeMars
Journal:  Science       Date:  1990-04-13       Impact factor: 47.728

4.  HLA-G is a potential tumor marker in malignant ascites.

Authors:  Gad Singer; Vera Rebmann; Yu-Chi Chen; Hsu-Tai Liu; Syed Z Ali; Jochen Reinsberg; Michael T McMaster; Kerstin Pfeiffer; Daniel W Chan; Eva Wardelmann; Hans Grosse-Wilde; Chih-Chien Cheng; Robert J Kurman; Ie-Ming Shih
Journal:  Clin Cancer Res       Date:  2003-10-01       Impact factor: 12.531

5.  Characterization of human leukocyte antigen-G (HLA-G) expression in endometrial adenocarcinoma.

Authors:  Breton F Barrier; Brian S Kendall; Kathy L Sharpe-Timms; Edward R Kost
Journal:  Gynecol Oncol       Date:  2006-03-10       Impact factor: 5.482

6.  HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis.

Authors:  Gad Singer; Robert J Kurman; Michael T McMaster; Ie-Ming Shih
Journal:  Am J Surg Pathol       Date:  2002-07       Impact factor: 6.394

7.  Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma.

Authors:  Jürgen Bukur; Vera Rebmann; Hans Grosse-Wilde; Hans Luboldt; Herbert Ruebben; Ingo Drexler; Gerd Sutter; Christoph Huber; Barbara Seliger
Journal:  Cancer Res       Date:  2003-07-15       Impact factor: 12.701

8.  Detection of HLA-G5 secreting cells.

Authors:  Vera Rebmann; Annika Busemann; Monica Lindemann; Hans Grosse-Wilde
Journal:  Hum Immunol       Date:  2003-11       Impact factor: 2.850

9.  Soluble HLA-G molecules are increased in lymphoproliferative disorders.

Authors:  Yasmine Sebti; Gaëlle Le Friec; Céline Pangault; Frédéric Gros; Bernard Drénou; Valérie Guilloux; Marc Bernard; Thierry Lamy; Renée Fauchet; Laurence Amiot
Journal:  Hum Immunol       Date:  2003-11       Impact factor: 2.850

10.  Secretion of sHLA-G molecules in malignancies.

Authors:  Vera Rebmann; Jens Regel; Dietmar Stolke; Hans Grosse-Wilde
Journal:  Semin Cancer Biol       Date:  2003-10       Impact factor: 15.707

View more
  7 in total

Review 1.  Clinical and biological significance of HLA-G expression in ovarian cancer.

Authors:  Jim Jinn-Chyuan Sheu; Ie-Ming Shih
Journal:  Semin Cancer Biol       Date:  2007-07-03       Impact factor: 15.707

2.  Interaction of MRE11 and Clinicopathologic Characteristics in Recurrence of Breast Cancer: Individual and Cumulated Receiver Operating Characteristic Analyses.

Authors:  Cheng-Hong Yang; Sin-Hua Moi; Li-Yeh Chuang; Shyng-Shiou F Yuan; Ming-Feng Hou; Yi-Chen Lee; Hsueh-Wei Chang
Journal:  Biomed Res Int       Date:  2017-01-04       Impact factor: 3.411

3.  Transcriptome profiles of carcinoma-in-situ and invasive non-small cell lung cancer as revealed by SAGE.

Authors:  Kim M Lonergan; Raj Chari; Bradley P Coe; Ian M Wilson; Ming-Sound Tsao; Raymond T Ng; Calum Macaulay; Stephen Lam; Wan L Lam
Journal:  PLoS One       Date:  2010-02-11       Impact factor: 3.240

4.  Unfavourable clinical implications for HLA-G expression in acute myeloid leukaemia.

Authors:  W-H Yan; A Lin; B-G Chen; W-D Luo; M-Z Dai; X-J Chen; H-H Xu; B-L Li
Journal:  J Cell Mol Med       Date:  2008-06       Impact factor: 5.310

5.  Human leukocyte antigen (HLA)-G gene polymorphism in patients with non-small cell lung cancer.

Authors:  Aneta Kowal; Andrzej Wiśniewski; Piotr Kuśnierczyk; Renata Jankowska
Journal:  Thorac Cancer       Date:  2015-02-28       Impact factor: 3.500

6.  Cumulative receiver operating characteristics for analyzing interaction between tissue visfatin and clinicopathologic factors in breast cancer progression.

Authors:  Sin-Hua Moi; Yi-Chen Lee; Li-Yeh Chuang; Shyng-Shiou F Yuan; Fu Ou-Yang; Ming-Feng Hou; Cheng-Hong Yang; Hsueh-Wei Chang
Journal:  Cancer Cell Int       Date:  2018-02-09       Impact factor: 5.722

Review 7.  Puzzling out the COVID-19: Therapy targeting HLA-G and HLA-E.

Authors:  Inès Zidi
Journal:  Hum Immunol       Date:  2020-10-07       Impact factor: 2.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.